US Federal

NIST Eliminates Obsolete Regulations for Advanced Technology Program

The National Institute of Standards and Technology (NIST) has finalized a rule to remove obsolete regulations pertaining to the Advanced Technology Program and the Technology Innovation Program. This action aims to streamline regulations and remove outdated requirements.

Combatting Organized Retail Crime Act of 2025

The House Committee on the Judiciary reported H.R. 2853, the Combatting Organized Retail Crime Act of 2025. This bill requires annual reports and establishes a retail crime center, aiming to address organized retail crime.

CBO Publishes Long-Term Budget Outlook Data

The Congressional Budget Office (CBO) has published the data underlying its long-term budget outlook for 2026 to 2056. Instead of a full report, the agency is providing the raw data that would have been included, allowing interested parties to analyze the projections.

FDA Amends Animal Drug Approval and Withdrawal Rules

The Food and Drug Administration (FDA) has amended regulations concerning the approval and withdrawal of new animal drug applications. These changes are effective February 6, 2026, and impact the procedures for drug sponsors and the handling of drug approvals.

FDA Allows Spirulina Extract as Color Additive in Human Foods

The Food and Drug Administration (FDA) has issued a final rule allowing spirulina extract to be used as a color additive in human foods. This rule amends the list of color additives exempt from certification. The comment period for this rule closes on March 9, 2026.

FDA Amends Food Coloring Regulations for Beetroot Red

The Food and Drug Administration (FDA) has amended regulations concerning the use of beetroot red as a food coloring additive. This rule finalizes changes to the listing of color additives exempt from certification, specifically impacting beetroot red.

FDA Revokes Mutual Recognition of EU Pharma and Device Reports

The Food and Drug Administration (FDA) is revoking regulations that allowed for the mutual recognition of pharmaceutical Good Manufacturing Practice (GMP) reports and medical device quality system audit reports with the European Community. This action will impact the oversight and inspection processes for products traded between the US and the EU.

FDA Revokes Methods of Analysis Regulation

The Food and Drug Administration (FDA) is revoking its regulation concerning methods of analysis. This rule, published in the Federal Register, will be effective March 23, 2026. The revocation impacts how certain analytical methods are regulated.

Proposed Amendments to Form N-PORT Reporting for Investment Companies

The Securities and Exchange Commission has proposed amendments to Form N-PORT reporting requirements for investment companies and ETFs. This proposal includes changes to the data elements and reporting format, with a comment period ending on April 24, 2026.

SEC Extends Form N-PORT Compliance Dates

The Securities and Exchange Commission (SEC) has extended the compliance dates for Form N-PORT reporting for investment companies. This rule change, published on February 23, 2026, provides additional time for affected entities to comply with the reporting requirements.